Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lipigon Pharmaceuticals AB | 4,053,000 | net | 25 Jul 2025 | tx 14+4,588,000−535,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Jul 2025 | GRANT_AWARD | Lipigon Pharmaceuticals AB | 3,600,000 | 0.04 SEK | deriv |
| 24 Jul 2025 | SALE | Lipigon Pharmaceuticals AB | 2,800 | 0.14 SEK | |
| 24 Jul 2025 | SALE | Lipigon Pharmaceuticals AB | 50,000 | 0.14 SEK | |
| 25 Jul 2025 | SALE | Lipigon Pharmaceuticals AB | 252,128 | 0.14 SEK | |
| 25 Jul 2025 | SALE | Lipigon Pharmaceuticals AB | 5,000 | 0.14 SEK | |
| 25 Jul 2025 | SALE | Lipigon Pharmaceuticals AB | 28,880 | 0.14 SEK | |
| 25 Jul 2025 | SALE | Lipigon Pharmaceuticals AB | 2,043 | 0.14 SEK | |
| 25 Jul 2025 | SALE | Lipigon Pharmaceuticals AB | 20,216 | 0.14 SEK | |
| 25 Jul 2025 | SALE | Lipigon Pharmaceuticals AB | 22,704 | 0.14 SEK | |
| 25 Jul 2025 | SALE | Lipigon Pharmaceuticals AB | 10,000 | 0.14 SEK | |
| 25 Jul 2025 | SALE | Lipigon Pharmaceuticals AB | 137,749 | 0.14 SEK | |
| 25 Jul 2025 | SALE | Lipigon Pharmaceuticals AB | 3,480 | 0.14 SEK | |
| 21 May 2025 | PURCHASE | Lipigon Pharmaceuticals AB | 728,000 | 0.09 SEK | |
| 16 Dec 2024 | PURCHASE | Lipigon Pharmaceuticals AB | 260,000 | 0.20 SEK |